Back to MW MARSHALL WACE, LLP

PMVPPMVP
Showing 7 of 19 quarters

Position history for MWMARSHALL WACE, LLP's holdings in PMV PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 321,610 shares of PMVP (PMV PHARMACEUTICALS INC), worth $430,956 as of 2026-Q2. The position was decreased (-25.9% shares). PMVP represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$430,956

Current Shares

321,610

Total Value Change

+$339,036

Total Shares Change

+259,919

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
321,610
-25.9%
$430,9560.0%$1.34
0
2026-Q1
Decreased
434,093
-6.7%
$538,2760.0%$1.62
0
2025-Q4
Decreased
465,086
-24.1%
$581,3580.0%$1.22
0
2025-Q3
New
612,626
-
$857,6770.0%$1.45
34
2025-Q1
Exited
0
-100.0%
$00.0%$1.11
0
2024-Q4
Decreased
11,014
-82.2%
$16,6310.0%$1.49
0
2024-Q3
Increased
61,691
+378.2%
$91,9200.0%$1.50
35

Other major holders of PMVP: VIKING GLOBAL INVESTORS LP, Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used